Orphan expands into Asia-Pacific market with new Australian office

  • 📰 businessposthq
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 71%

United States News News

United States United States Latest News,United States United States Headlines

Orphan, the Irish drug consulting company, which helps pharma firms through the process of launching drugs onto the market, is aiming to be ‘truly global’.

Orphan Drug Consulting, an Irish company that helps pharmaceutical businesses through the process of launching drugs onto the market, is expanding its operations with the opening of a new Australian office focused on the Asia-Pacific market.

Kelly, a veteran of the pharmaceutical industry, founded Orphan Drug Consulting to fill a gap she had noticed while working at a number of pharma companies over a 15-year period. Today, the Enterprise Ireland-backed company has offices in London, Boston and Dublin, and employs 25 full-time staff. In addition, through the help it gives early-stage drug companies, it has played an indirect role in providing employment to many more people, according to Kelly.

The company has helped firms develop treatments for cystic fibrosis as well as several other drugs for lesser-known illnesses. “Quite a lot of them are paediatric, and a large volume are oncologic as well,” Kelly said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 8. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Finnish tech company Supermetrics to create 100 jobs as it opens Irish officeFinnish tech company Supermetrics to create 100 jobs as it opens Irish office via IrishTimesBiz
Source: IrishTimesBiz - 🏆 6. / 77 Read more »